The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s chimeric antigen receptor T (CAR-T) cells market report forecasts the chimeric antigen receptor T (CAR-T) cells market size to grow to $10.24 Billion by 2027, with a CAGR (compound annual growth rate) of more than 38%.

Learn More On The Chimeric Antigen Receptor T (CAR-T) Cells Market Report 2023 – https://www.thebusinessresearchcompany.com/report/chimeric-antigen-receptor-t-car-t-cells-global-market-report

Chimeric Antigen Receptor T (CAR-T) Cells Market Size Forecast
The global chimeric antigen receptor T (CAR-T) cells market is expected to grow from $1.96 billion in 2022 to $2.76 billion in 2023 at a compound annual growth rate (CAGR) of 40.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The chimeric antigen receptor T (CAR-T) cells market size is expected to grow to $10.24 billion in 2027 at a CAGR of 38.8%.

North America held the largest chimeric antigen receptor T (CAR-T) cells market share.

Key Chimeric Antigen Receptor T (CAR-T) Cells Market Driver ­– Increase In Occurrences Of Cancer
For instance, in 2021, according to the American Cancer Society, a voluntary health organization, global cancer patients diagnosed is expected to reach 1.9 million in 2021. Due to population growth and ageing, the worldwide burden of cancer is predicted to reach 27.5 million new cases and 16.2 million cancer deaths by 2040. Therefore, the rising prevalence of cancer is anticipated to boost the chimeric antigen receptor T (CAR-T) cells market in the upcoming years.

Request for A Sample Of The Global Chimeric Antigen Receptor T (CAR-T) Cells Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8124&type=smp

Key Chimeric Antigen Receptor T (CAR-T) Cells Market Trend – Product Innovation
Major market players operating in the chimeric antigen receptor T (CAR-T) cells market are concentrating their efforts on creating innovative technologies to develop novel CAR-T cell-based treatments. For instance, in December 2021, Novartis AG, a Switzerland-based pharmaceutical company specializing in the development and manufacturing of drugs, launched the T-Charge CAR-T platform. This technology-enabled platform enables the body to renew and mature CAR-T cells, offering a greater proliferative environment for cells.

Chimeric Antigen Receptor T (CAR-T) Cells Market Segment
1) By Target Antigen: CD19, CD22, Other Antigens
2) By Application: Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Other Applications
3) By End User: Hospitals, Cancer Research Centres, Clinics

Chimeric Antigen Receptor T (CAR-T) Cells Market Major Players and Strategies
Major players in the chimeric antigen receptor T (CAR-T) cells market are Novartis International AG, Pfizer Inc., Gilead Sciences Inc., Autolus Therapeutics Plc, CARsgen Therapeutics Company Limited, Bristol-Myers Squibb Company, Sorrento Therapeutics Inc., Legend Biotech, Mustang Bio Inc., Bluebird Bio Inc., and Eureka Therapeutics Inc.

In November 2021, Laurus Labs, an India-based pharmaceutical and biotechnology company, acquired a substantial minority stake (26.62%) in Immunoadoptive Cell Therapy (ImmunoACT) for $5.56 million (INR 0.46 billion). With this acquisition, Laurus Labs will strengthen its biologics business and gain access to an emerging field of research. Immunoadoptive Cell Therapy is an India-based CAR-T cell-therapy company.

The Chimeric Antigen Receptor T (CAR-T) Cells Global Market Report 2023 covers regional data on chimeric antigen receptor T (CAR-T) cells market size, chimeric antigen receptor T (CAR-T) cells market trends and drivers, opportunities, strategies, and chimeric antigen receptor T (CAR-T) cells market competitor analysis. The countries covered in the chimeric antigen receptor T (CAR-T) cells market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The chimeric antigen receptor T (CAR-T) cells refers to genetically engineered cells that fight with cancer cells to treat the disease. The chimeric antigen receptor T (CAR-T) cell therapy is a form of treatment in which the patient’s T cells, a particular type of immune system cell, are altered in a lab so they will target cancer cells. Blood from a patient is drawn to get T cells. Then, in the lab, T cells are given the gene for a unique receptor, chimeric antigen receptor T (CAR-T), that attaches to a particular protein on the patient’s cancer cells and helps fight cancer.

View More Reports Related To The Chimeric Antigen Receptor T (CAR-T) Cells Market –
Monoclonal Antibodies MAbS Global Market Report 2023
Checkpoint Inhibitors Global Market Report 2023
Cellular Immunotherapy Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: